Arvinas (ARVN) EBT Margin (2017 - 2026)

Arvinas (ARVN) posted quarterly EBT Margin of 368.59% for Q1 2026, down 41260.0% year-over-year from N/an in Q1 2025, and up 47.89% quarter-over-quarter from 707.37% in Q4 2025.

Arvinas (ARVN) EBT Margin (2017 - 2026) Analysis & Trends

Arvinas' EBT Margin history runs 10 years deep, the most recent figure standing at 368.59% for Q1 2026.

  • In Q1 2026, EBT Margin fell 41260.0% year-over-year to 368.59%; the TTM figure through Mar 2026 stood at 247.2% (down 23643.0% YoY), while the FY2025 annual figure was 30.65%, up 4463.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 368.59%, up from 707.37% in the prior quarter.
  • The five-year high for EBT Margin was 355.45% in Q4 2023, with the low at 707.37% in Q4 2025.
  • The 5-year median for EBT Margin is 184.04% (2022), against an average of 164.92%.
  • The sharpest annual moves came in 2022 and 2025: EBT Margin surged 72490 bps in 2022, then plunged 63051 bps in 2025.
  • Arvinas' EBT Margin stood at 183.33% in 2022, then jumped by 294 bps to 355.45% in 2023, then sank by 122 bps to 76.86% in 2024, then sank by 820 bps to 707.37% in 2025, then surged by 48 bps to 368.59% in 2026.
  • Business Quant data shows ARVN's EBT Margin at 368.59% in Q1 2026, 707.37% in Q4 2025, and 83.05% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Arvinas 585.74 Mn 17.84 Mn - 67.92%

Historic Data

Download Data
DateValue
Jun 30, 2026 67.92%
Mar 31, 2026 -368.59%
Dec 31, 2025 -707.37%
Sep 30, 2025 -83.05%
Jun 30, 2025 -274.55%
Mar 31, 2025 44.01%
Dec 31, 2024 -76.86%
Sep 30, 2024 -47.46%
Jun 30, 2024 -45.75%
Mar 31, 2024 -273.91%
Dec 31, 2023 355.45%
Sep 30, 2023 -184.68%
Jun 30, 2023 -120.37%
Mar 31, 2023 -249.85%
Dec 31, 2022 -183.33%
Sep 30, 2022 -184.04%
Jun 30, 2022 -189.64%
Mar 31, 2022 -213.58%
Dec 31, 2021 -138.86%
Sep 30, 2021 -503.23%